cytidine diphosphate choline has been researched along with Cognition Disorders in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.23) | 18.2507 |
2000's | 14 (45.16) | 29.6817 |
2010's | 13 (41.94) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Authors | Studies |
---|---|
Antonelli Incalzi, R; Bonvicini, M; Lelli, D; Pedone, C; Travaglini, S | 1 |
Bokova, IA; Shavlovskaya, OA | 1 |
Nemkova, SA; Petrova, EA; Savchenko, DV; Semenov, DV; Vozvyshaeva, MY; Zavadenko, NN | 1 |
Bogacheva, TE; Demidov, VI; Grishina, TR; Gromova, OA; Torshin, IY | 1 |
Bitchuk, N; Dubivska, S; Grigorov, Y; Kudinova, O | 1 |
Anisimova, TI; Chutko, LS; Didur, MD; Karpovskaya, EB; Surushkina, SY; Vasilenko, VV; Volov, MB; Yakovenko, EA | 1 |
Alvarez-Sabín, J; Jacas, C; Maisterra, O; Molina, C; Ortega, G; Quintana, M; Ribo, M; Román, GC; Santamarina, E | 1 |
Brown, CH; Deutsch, SI; Rosse, RB; Rosse, SM; Schooler, NR; Schwartz, BL | 1 |
Formiga, F; Robles, MJ; Vidán, MT | 1 |
Bruni, AC; Castagna, A; Cotroneo, AM; De Sarro, G; Gareri, P; Putignano, S | 1 |
Baker, R; Jackson, D | 1 |
Abdelmonem, S; El Sayed, I; Fayed, AM; Shehata, GM; Zaki, A | 1 |
Agrawal, N; Poole, NA | 1 |
Saver, JL | 1 |
Díez-Tejedor, E; Frank-García, A; García-Cobos, R; Gutiérrez-Fernández, M | 1 |
Secades, JJ | 1 |
Ansel, BM; Bagiella, E; Diaz-Arrastia, R; Dikmen, SS; Eisenberg, H; Friedewald, WT; Hart, T; Hesdorffer, DC; Jallo, J; Melton, S; Merchant, RE; Novack, TA; Ricker, JH; Temkin, NR; Timmons, SD; Zafonte, RD | 1 |
Riechers, RG; Ruff, RL | 1 |
Higgins, JP; Thompson, SG | 1 |
Browndyke, JN; Cohen, RA; Garrett, KD; Gordon, N; Moser, D; Ott, BR; Paul, RH; Shah, P; Sweet, LH | 1 |
Browndyke, J; Cohen, RA; Garrett, K; Malloy, P; Moser, DJ; Ott, BR; Paul, RH; Sethi, M; Sweet, L | 1 |
Conant, R; Schauss, AG | 1 |
Fioravanti, M; Yanagi, M | 4 |
Lorenzo, JL; Secades, JJ | 1 |
Amenta, F; Mignini, F; Parnetti, L; Tomassoni, D; Traini, E | 1 |
Buckley, AE; Fioravanti, M | 1 |
Di Trapani, G; Fioravanti, M | 1 |
15 review(s) available for cytidine diphosphate choline and Cognition Disorders
Article | Year |
---|---|
Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
Topics: Alzheimer Disease; Cognition; Cognition Disorders; Cognitive Dysfunction; Cytidine Diphosphate Choline; Humans | 2023 |
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
Topics: Cognition Disorders; Cytidine Diphosphate Choline; Humans; Nootropic Agents | 2015 |
A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.
Topics: Adult; Amino Acids; Brain Injuries, Traumatic; Cognition Disorders; Cytidine Diphosphate Choline; Glasgow Outcome Scale; Humans; Neuroprotective Agents; Piracetam; Treatment Outcome | 2018 |
Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.
Topics: Brain Injuries; Cholinesterase Inhibitors; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Lecithins; Neuropsychological Tests; Nootropic Agents; Physostigmine; Surface-Active Agents; Time Factors | 2008 |
Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
Topics: Acetylcholine; Animals; Cell Membrane; Clinical Trials as Topic; Cognition Disorders; Craniocerebral Trauma; Cytidine Diphosphate Choline; Dopamine; Fatty Acids, Nonesterified; Glaucoma; Humans; Meta-Analysis as Topic; Nerve Regeneration; Neurons; Neuroprotective Agents; Optic Neuropathy, Ischemic; Parkinson Disease; Phospholipids; Stroke | 2008 |
Citicoline, use in cognitive decline: vascular and degenerative.
Topics: Animals; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Disease Models, Animal; Humans; Nootropic Agents | 2010 |
Citicoline: pharmacological and clinical review, 2010 update.
Topics: Brain Injuries; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Learning; Memory; Stroke; Synaptic Transmission | 2011 |
Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Topics: Alzheimer Disease; Animals; Brain Injuries; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Models, Animal; Nootropic Agents; Stroke | 2004 |
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Humans; Mental Disorders; Nootropic Agents; Randomized Controlled Trials as Topic | 2004 |
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Humans; Memory; Mental Disorders; Nootropic Agents; Randomized Controlled Trials as Topic | 2005 |
Citicoline: pharmacological and clinical review, 2006 update.
Topics: Animals; Brain Diseases; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Lethal Dose 50; Neuroprotective Agents; Nootropic Agents | 2006 |
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Topics: Acetylcholine; Animals; Brain; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Glycerylphosphorylcholine; Humans; Neuroprotective Agents; Nootropic Agents; Phospholipids | 2007 |
Citicoline (Cognizin) in the treatment of cognitive impairment.
Topics: Cognition Disorders; Cytidine Diphosphate Choline; Humans; Italy | 2006 |
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Topics: Aged; Cerebrovascular Disorders; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Humans; Mental Disorders; Nootropic Agents | 2000 |
Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Topics: Aged; Cerebrovascular Disorders; Cognition Disorders; Cytidine Diphosphate Choline; Dementia; Humans; Mental Disorders; Nootropic Agents | 2000 |
6 trial(s) available for cytidine diphosphate choline and Cognition Disorders
Article | Year |
---|---|
[Current treatment options for autonomic, cognitive and emotional disorders in patients with asthenic syndrome treated with recognan (citicoline)].
Topics: Adolescent; Adult; Affective Symptoms; Asthenia; Cognition; Cognition Disorders; Cytidine Diphosphate Choline; Female; Humans; Male; Nootropic Agents; Syndrome; Young Adult | 2019 |
Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Cognition; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Disability Evaluation; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Odds Ratio; Predictive Value of Tests; Recovery of Function; Spain; Stroke; Stroke Rehabilitation; Time Factors; Treatment Outcome; Young Adult | 2013 |
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.
Topics: Adult; Aged; alpha7 Nicotinic Acetylcholine Receptor; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Synaptic Transmission; Treatment Outcome | 2013 |
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Topics: Adolescent; Adult; Brain Injuries; Cognition Disorders; Cytidine Diphosphate Choline; Double-Blind Method; Female; Glasgow Coma Scale; Humans; Male; Middle Aged; Nootropic Agents; Severity of Illness Index; Trauma Centers; Treatment Outcome; Young Adult | 2012 |
Neuroimaging correlates of dementia rating scale performance at baseline and 12-month follow-up among patients with vascular dementia.
Topics: Aged; Basal Ganglia; Brain; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Double-Blind Method; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Nootropic Agents; Severity of Illness Index; Thalamus | 2003 |
Clinical correlates of cognitive decline in vascular dementia.
Topics: Aged; Analysis of Variance; Basal Ganglia; Body Weights and Measures; Brain; Brain Infarction; Cerebral Cortex; Cognition Disorders; Cytidine Diphosphate Choline; Dementia, Vascular; Double-Blind Method; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Nootropic Agents; Predictive Value of Tests; Severity of Illness Index; Thalamus | 2003 |
10 other study(ies) available for cytidine diphosphate choline and Cognition Disorders
Article | Year |
---|---|
[Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].
Topics: Adolescent; Cognition Disorders; Cognitive Dysfunction; Cytidine Diphosphate Choline; Humans; Ischemic Stroke; Nootropic Agents | 2023 |
[Molecular and clinical aspects of the effect of cytidyndiphosphocholine on cognitive functions].
Topics: Brain Ischemia; Cognition; Cognition Disorders; Cytidine Diphosphate Choline; Humans; Nootropic Agents | 2021 |
[TACTICS OF CHOOSING COGNITIVE DYSFUNCTION THERAPY IN THE POSTOPERATIVE PERIOD].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cognition Disorders; Cytidine Diphosphate Choline; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; Neuroprotective Agents; Neuropsychological Tests; Niacinamide; Postoperative Complications; Psychometrics; Succinates | 2017 |
[Impairments of cognitive control in patients with somatoform disorders and their treatment].
Topics: Adolescent; Adult; Cognition; Cognition Disorders; Cytidine Diphosphate Choline; Follow-Up Studies; Humans; Middle Aged; Nootropic Agents; Somatoform Disorders; Young Adult | 2019 |
[Delirium prevention and treatment in elderly hip fracture].
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Benzodiazepines; Cognition Disorders; Combined Modality Therapy; Confusion; Cytidine Diphosphate Choline; Delirium; Haloperidol; Hip Fractures; Hospitalization; Humans; Hypnotics and Sedatives; Length of Stay; Multicenter Studies as Topic; Narcotics; Nerve Block; Pain Management; Postoperative Complications; Randomized Controlled Trials as Topic | 2014 |
New models for describing outliers in meta-analysis.
Topics: Algorithms; Cognition Disorders; Cytidine Diphosphate Choline; Dental Caries; Fluorides; Humans; Hypercholesterolemia; Meta-Analysis as Topic; Models, Statistical; Monte Carlo Method; Paroxetine; Placebos; Pravastatin; Regression Analysis; Research Design; Software; Statistics as Topic; Toothpastes | 2016 |
Effective treatment of traumatic brain injury: learning from experience.
Topics: Brain Injuries; Cognition Disorders; Cytidine Diphosphate Choline; Female; Humans; Male; Nootropic Agents | 2012 |
Quantifying heterogeneity in a meta-analysis.
Topics: Albumins; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cognition Disorders; Cytidine Diphosphate Choline; Fibrosis; Fracture Fixation; Hip Fractures; Humans; Meta-Analysis as Topic; Resuscitation; Sarcoma; Sclerotherapy; Statistics as Topic | 2002 |
Citicoline. Monograph.
Topics: Amblyopia; Amyloid beta-Peptides; Bipolar Disorder; Brain Injuries; Cell Membrane; Cognition Disorders; Cytidine Diphosphate Choline; Glaucoma; Humans; Intracranial Hemorrhages; Neurotransmitter Agents; Phosphatidylcholines; Spinal Cord Injuries; Stroke | 2008 |
[Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline].
Topics: Age Factors; Aged; Cognition Disorders; Cytidine Diphosphate Choline; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Time Factors | 1991 |